Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells

British Journal of Pharmacology

Volumn 119, Issue 7, 1996, Pages 1463-1469

  Shimoni, Y ^a   Han, X ^a   Severson, D ^a   Giles, W R ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Adenosine; Adrenergic tone; Cardiac pacemaker cells; L type calcium current; Nitric oxide

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; 6 N CYCLOPENTYLADENOSINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; CYCLIC GMP; GUANYLATE CYCLASE; ISOPRENALINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM ION; PURINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE CELL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RABBIT; SINUS NODE; VOLTAGE CLAMP;

EID: 0029851164     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16059.x     Document Type: Article

References (43)

1. BALLIGAND, J.L., KELLY, R.A., MARSDEN, P.A., SMITH, T.W. & MICHEL, T. (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc. Natl. Acad. Sci. U.S.A., 90, 347-351.
2. BELARDINELLI, L., GILES, W.R. & WEST, A. (1988). Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J. Physiol., 405, 615-633.
3. BELARDINELLI, L. & LERMAN, B.B. (1991). Adenosine: cardiac electrophysiology. PACE, 14, 1672-1680.
4. BELARDINELLI, L., LINDEN, J. & BERNE, R.M. (1989). The cardiac effects of adenosine. Prog. Cardiovasc. Dis., 32, 73-97.
5. BELARDINELLI, L., SHRYOCK, J.C., SONG, Y., WANG, D. & SRINIVAS, M. (1995). Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J., 9, 359-365.
6. BREDT, D.S. & SNYDER, S.H. (1990). Nitric oxide, a novel second messenger. Neuron, 8, 3-11.
7. CORDEIRO, J.M., FERRIER, G.R. & HOWLETT, S.E. (1995). Effects of adenosine in simulated ischemic and reperfusion in guinea pig ventricular myocytes. Am. J. Physiol., 269, H121-H129.
8. DIMARCO, J.P., SELLER, T.S., BERNE, R.M., WEST, G.A. & BELLARDINELLI, L. (1983). Adenosine: Electrophysiological effects and therapeutic use of terminating paroxysmal supraventricular tachycardia. Circ., 68, 1254-1263.
9. 2+ current inhibition. Surgery, 114, 334-342.
10. FISCHMEISTER, R. & HARTZELL, H.C. (1987). Cyclic guanosine 3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J. Physiol., 387, 453-472.
11. 2+ current in adult rabbit atrioventricular nodal cells. Circ. Res., 78, 998-1008.
12. HAN, X., SHIMONI, Y. & GILES, W.R. (1994). An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J. Physiol., 476, 309-314.
13. HAN, X., SHIMONI, Y. & GILES, W.R. (1995). A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J. Gen. Physiol., 106, 45-65.
14. HORN, R. & MARTY, A. (1988). Muscarinic activation of ionic currents measured by a new whole-cell recording method. J. Gen. Physiol., 92, 145-159.
15. HOSHIDA, S., YAMASHITA, N., IGARISHI, J., NISHIDA, M., HORI, M., KAMADA, T., KUZUYA, T. & TADA, M. (1995). Nitric oxide synthase protects the heart against ischemia-reperfusion injury in rabbits. J. Pharmacol. Exp. Ther., 274, 413-418.
16. IRISAWA, H., BROWN, H.F. & GILES, W.R. (1993). Cardiac pacemaking in the sinoatrial node. Physiol. Rev., 73, 197-227.
17. ISENBERG, G. & KLOCKNER, U. (1982). Calcium tolerant ventricular myocytes prepared by preincubation in a 'KB' medium. Pflügers Arch., 395, 6-18.
18. KABELL, G., BUCHANAN, L.V., GIBSON, J.K. & BELARDINELLI, L. (1994). Effects of adenosine on atrial refractoriness and arrhythmias. Cardiovasc. Res., 28, 1385-1389.
19. Ca by carbachol and sodium nitroprusside. Pflügers Arch., 426, 419-426.
20. 1 receptors in rabbit heart. Circ., 84, 350-356.
21. MALINSKI, T. & TAHA, Z. (1992). Nitric oxide release from a single cell measured in situ by a porphyrinic-based microsensor. Nature, 358, 676-678.
22. MARTYNYUK, A.E., KANE, K.A., COBBE, S.M. & RANKIN, A.C. (1996). Nitric oxide mediates the anti-adrenergic effect of adenosine on calcium current in isolated rabbit atrioventricular nodal cells. Pflügers Arch., 431, 452-457.
23. 2+ current. J. Biol. Chem., 268, 26286-26295.
24. MERY, P.-F., PAVOINE, C., BELHASSEN, L., PECKER, F. & FISCHMEISTER, R. (1995). Erythro-9-(2-Hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes. Mol. Pharmacol., 48, 121-130.
25. 3 receptors regulate serotonin transport via nitric oxide and cGMP. J. Biol. Chem., 269, 27351-27356.
26. MONCADA, S., PALMER, R.S. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev., 433, 109-142.
27. MUBAGWA, K., SHIRAYAMA, T., MOREAU, M. & PAPPANO, A.J. (1993). Effects of PDE inhibitors and carbachol on the L-type Ca current in guinea pig ventricular myocytes. Am. J. Physiol., 264, H1353-H1363.
28. NAWRATH, H., BAUMNER, D., RUPP, J. & HELLMUT, O. (1995). The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br. J. Pharmacol., 116, 3061-3067.
29. OLAH, M.E. & STILES, G.L. (1995). Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol., 35, 581-606.
30. OLSSON, R.A. & PEARSON, J.D. (1990). Cardiovascular purinoceptors. Physiol. Rev., 70, 761-845.
31. PARRATT, J. (1993). Endogenous myocardial protective (antiarrhythmic) substances. Cardiovasc. Res., 27, 693-702.
32. PELLEG, A. & BELARDINELLI, L. (1993). Cardiac electrophysiology and pharmacology of adenosine: basic and clinical aspects. Cardiovasc. Res., 27, 54-61.
33. 2+ current by adenosine in ferret isolated right ventricular myocytes. J. Physiol., 471, 269-293.
34. RANKIN, A.C., BROOKS, R., RUSKIN, J.N. & MCGOVERN, B.A. (1992). Adenosine and the treatment of supraventricular tachycardia. Am. J. Med., 92, 655-664.
35. RUDOLPHI, K.A., SCHUBERT, P., PARKINSON, F.E. & FREDHOLM, B.B. (1992). Neuroprotective role of adenosine in cerebral ischaemia. Trends Pharmacol. Sci., 13, 439-445.
36. SCHMIDT, H.H.W., LOHMANN, S.M. & WALTER, U. (1993). The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim. Biophys. Acta, 1178, 153-175.
37. SCHMIDT, M.J., SAWYER, B.D., TRUEX, L.L., MARSHALL, W.S & FLEISCH, J.H. (1984). LY83583: an agent that lowers intracellular levels of cyclic guanosine 3′,5′-monophosphate. J. Pharmacol. Exp. Ther., 232, 764-769.
38. SHEN, W.-K. & KURACHI, Y. (1995). Mechanisms of adenosine-mediated actions on cellular and clinical cardiac electrophysiology. Mayo Clin. Proc., 70, 274-291.
39. STILES, G.L. (1990). Adenosine receptors and beyond: molecular mechanisms of physiological regulation. Clin. Res., 38, 10-18.
40. STONE, T.W. (1981). Physiological roles for adenosine and adenosine 5′-triphosphate in the nervous system. Neurosci., 6, 523-555.
41. WANG, D. & BELARDINELLI, L. (1994). Mechanism of the negative inotropic effect of adenosine in guinea pig atrial myocytes. Am. J. Physiol., 267, H2420-H2429.
42. WANG, D., SHYROCK, J.C. & BELARDINELLI, L. (1996). Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells. Circ. Res., 78, 697-707.
43. ZAKHAROV, S.I., PIERAMICI, S., KUMAR, G.K., PRABHAKAR, N.R. & HARVEY, R.D. (1996). Nitric oxide synthase activity in guinea pig ventricular myocytes is not involved in muscarinic inhibition of cAMP-regulated ion channels. Circ. Res., 78, 925-935.